U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07140679) titled 'Immunotherapy (Toripalimab) for Preventing Recurrence After Surgery for Mismatch Repair Deficient Stage IIB, IIC, or III Colon Cancer' on Aug. 22.
Brief Summary: This phase II trial tests how well immunotherapy (toripalimab) works for preventing cancer recurrence after surgery in patients with mismatch repair deficient stage IIB, IIC, or III colon cancer.
Study Start Date: Sept. 08
Study Type: INTERVENTIONAL
Condition:
Localized Colon Carcinoma
Stage IIB Colon Cancer AJCC v8
Stage IIC Colon Cancer AJCC v8
Stage III Colon Cancer AJCC v8
Intervention:
PROCEDURE: Biopsy Procedure
Undergo biopsy
PROCEDURE: Biospecimen Collection...